Start for free
Start for free
AB

Avego Bioscience Capital

North America, Georgia, United States, Alpharetta

Description

Avego Bioscience Capital is an investment firm.

Investor Profile

Avego Bioscience Capital has made 6 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Series B (33%)
  • Series D (17%)

Country Focus

  • United States (83%)
  • Switzerland (17%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
  • Medical Device
  • Bioinformatics
  • Oncology
  • Life Science
  • Manufacturing
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Avego Bioscience Capital frequently co-invest with?

Altium Capital
Altium Capital
North America, New York, United States, New York
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Monashee Investment Management
Monashee Investment Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Amzak Health Investors
Amzak Health Investors
North America, New York, United States, New York
Co-Investments: 1
Delos Capital
Delos Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
LV
LifeSci Venture Partners
North America, New York, United States, New York
Co-Investments: 2
AbbVie Biotech Ventures
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 2
Aisling Capital
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Avego Bioscience Capital often collaborate with?

JR
Jesse Robbins
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Avego Bioscience Capital?

TRex Bio

South San Francisco, California, United States

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

BioinformaticsBiopharmaBiotechnology
Series BNov 13, 2024
Amount Raised: $84,000,000
Alentis Therapeutics

Allschwil, Basel-Landschaft, Switzerland

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Series DNov 12, 2024
Amount Raised: $181,400,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics
Series BNov 3, 2021
Amount Raised: $75,000,000
Ribon Therapeutics

Cambridge, Massachusetts, United States

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series CJun 14, 2021
Amount Raised: $65,000,000
Caribou Biosciences

Berkeley, California, United States

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

BiotechnologyHealth CareOncologyTherapeutics
Series CMar 3, 2021
Amount Raised: $115,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator